Skip to main content

Visit our other sites

jnj.com
jnjinnovation network
Quickfire Challenges

Main navigation

Home
About us
Partner with us
Blog
News
Challenges
Video hub
Connect with Us

News

Maintabs

All news
Press releases
In the media
Partner news
Social
Other News

Article view
List view

Refine by

Refine by

Type

(-) JNJ Press releases
Other news
(-) Partner news
Press release

Period

(-) 2020
2018
2016
2015
2013
2012
2011
2009

Jan
Mar
Apr
May
Jun
Jul
(-) Aug
Sep
Nov
Dec

Locations & regions

Focus area

Clear filters

News

Rodeo Therapeutics Nominates First-in-Class Oral Development Candidate for Inflammatory Bowel Disease

Read full story

JNJ Press releases

Johnson & Johnson Innovation and Janssen Announce the Awardees of the World Without Disease Call-for-Proposal

Read full story

GI Windows Raises $16.4M in Series A-1 Financing

Read full story

Johnson & Johnson to Acquire Momenta Pharmaceuticals, Inc., Expanding Janssen’s Leadership in Novel Treatments for Autoimmune Diseases

Read full story

ImmPACT Bio USA Inc. Raises $18 Million In Series A Financing

Read full story

Thirty Madison Raises $47M in Series B Financing From Polaris Partners, Johnson & Johnson Innovation - JJDC, Inc. and Existing Investors

Read full story

ViaCyte and Gore Enter Clinical Phase Agreement Based on Novel Membrane Technology for PEC-Encap Product Candidate

Read full story

Sidebar

Currently trending

Currently trending

Locus Biosciences Announces $35 Million Financing
VantAI Announces Multi-Year Protein Degrader Discovery Collaboration with Janssen
Bioasis Enters Into Research Collaboration With Janssen
Rondo Therapeutics Closes $67 Million Series A Financing to Advance Next-Generation Immuno-Oncology Platform for Solid Tumors
Biocom conference charts prospects for life sciences industry amid stock market volatility
Remix Therapeutics Enters Collaboration with Janssen to Advance Small Molecule Therapeutics Using REMaster Drug Discovery Platform to Modulate RNA Processing
VerImmune Inc Announces Research Collaboration with Janssen to Leverage its Unique Immuno-oncology Therapeutic Platform
Mersana Therapeutics Announces Research Collaboration and License Agreement with Janssen to Advance Novel Antibody-Drug Conjugates
CRISPR Therapeutics and ViaCyte, Inc. Announce First Patient Dosed in Phase 1 Clinical Trial of Novel Gene-Edited Cell Replacement Therapy for Treatment of Type 1 Diabetes (T1D)
Navitor Pharmaceuticals Announces Janssen Has Acquired Anakuria Therapeutics, Inc.

Trending

Trending

A JLABS Collaboration: DC4U

A JLABS Collaboration: Neurocast

Johnson & Johnson Innovation: Our Partnership Story